drugset
drugset / Trial / NCT03743155

Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy

NCT03743155 ↗

Phase 2 Unknown 10 enrolled Institut de Terapia Regenerativa Tissular
NaSingle-groupOpen-labelTreatment

Summary

Phase II not controlled, open-label, prospective, single center clinical trial

Timeline

Start
2018-12-15
Primary completion
2019-05-30
Completion
2021-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal cells Cell therapy — —

Indications

No indication recorded.